Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent chemoradiotherapy with gemcitabine followed by gemcitabine + cisplatin for unresectable localized perihilar cholangiocarcinoma
KCT0003478Phase 2Withdrawn
- Sponsor
- Dong-A ST
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, cisplatin in cholangiocarcinoma (CCA), sponsored by Dong-A ST. Planned start May 2018; status: withdrawn.
02
Drugs
gemcitabinecisplatin
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on KCT0003478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003478.